独立董事专门会议决议 珠海光库科技股份有限公司（以下简称"公司"）关于发行股份、可转换公 司债券及支付现金购买资产并募集配套资金暨关联交易事项的独立董事专门会 议于 2025 年 8 月 11 日以现场结合通讯方式召开。本次独立董事专门会议通知及 会议材料已于 2025 年 8 月 7 日以电子邮件及直接送达方式向公司全体独立董事 发出。经全体独立董事推举，会议由独立董事陶晓慧主持。本次会议应出席独立 董事 3 名，实际出席独立董事 3 名。本次会议的召集、召开符合相关法律、行政 法规、部门规章、规范性文件和公司章程的规定。会议决议如下： 一、审议通过《关于公司本次发行股份、可转换公司债券及支付现金购买资 产并募集配套资金暨关联交易符合相关法律法规规定条件的议案》 珠海光库科技股份有限公司 关于发行股份、可转换公司债券及支付现金 购买资产并募集配套资金暨关联交易事项的 公司拟通过发行股份、可转换公司债券及支付现金的方式购买张关明、苏州 讯诺投资合伙企业（有限合伙）（以下简称"讯诺投资"）、刘晓明、杜文刚、沙 淑丽、于壮成合计 6 名交易对方合计持有的苏州安捷讯光电科技股份有限公司 （以下简称"标的公司"）的 ...

截至本说明出具日，本次交易相关的审计、评估工作尚未完成，标的公司股份的 估值及定价尚未最终确定，根据标的公司未经审计的财务数据初步判断，预计本次交 易将达到《上市公司重大资产重组管理办法》规定的重大资产重组标准，预计构成上 市公司重大资产重组。 二、本次交易不构成重组上市 本次交易前 36 个月内，上市公司实际控制人未发生变更。本次交易前后，上市 公司实际控制人均为珠海市人民政府国有资产监督管理委员会，本次交易不会导致上 市公司控制权变更。 珠海光库科技股份有限公司董事会 关于本次交易预计构成重大资产重组及关联交易且不构成重组 上市的说明 珠海光库科技股份有限公司（以下简称"上市公司"或"公司"）拟以发行股份、 可转换公司债券及支付现金的方式向张关明、苏州讯诺投资合伙企业（有限合伙）、 刘晓明、杜文刚等 6 名交易对方购买苏州安捷讯光电科技股份有限公司（以下简称 "标的公司"）100%股权，并拟向不超过 35 名特定投资者发行股份募集配套资金（以 下简称"本次交易"）。 一、本次交易预计构成重大资产重组 珠海光库科技股份有限公司 董事会 根据《上市公司重大资产重组管理办法》的相关规定，本次交易不构成重组上市。 ...

证券代码：300620 证券简称：光库科技 公告编号：2025-049 珠海光库科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、会议召开情况 珠海光库科技股份有限公司（以下简称"公司"）于 2025 年 8 月 11 日以现 场结合通讯方式在公司会议室召开了第四届董事会第十六次会议，会议通知及会 议资料于 2025 年 8 月 7 日以电子邮件及直接送达方式送达全体董事。与会董事已 知悉本次会议所议事项的相关必要信息。本次会议由董事长郭瑾女士主持，应到董 事 9 人，实到董事 9 人。本次会议的召集、召开和表决程序符合《中华人民共和国 公司法》等法律、法规以及《珠海光库科技股份有限公司章程》的规定，合法有效。 二、会议审议情况 经与会董事审议并书面投票表决，通过如下议案： （一） 审议通过《关于公司本次发行股份、可转换公司债券及支付现金购买 资产并募集配套资金暨关联交易符合相关法律法规规定条件的议案》 公司拟通过发行股份、可转换公司债券及支付现金的方式购买张关明、苏州讯 诺投资合伙企业（有限合伙）（以下简称"讯诺投资"）、刘晓明、杜文刚、 ...

的有关规定，会议合法有效。 二、会议审议情况 经与会监事审议并书面投票表决，逐项通过如下议案： 证券代码：300620 证券简称：光库科技 公告编号：2025-050 珠海光库科技股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、会议召开情况 珠海光库科技股份有限公司（以下简称"公司"）第四届监事会第十一次会 议于 2025 年 8 月 11 日在公司会议室以现场结合通讯方式召开，本次应出席监事 舟先生主持，本次会议的召集、召开和表决程序符合《中华人民共和国公司法》 等法律、法规以及《珠海光库科技股份有限公司章程》 （以下简称"《公司章程》"） （一） 审议通过《关于公司本次发行股份、可转换公司债券及支付现金购 买资产并募集配套资金暨关联交易符合相关法律法规规定条件的议案》 公司拟通过发行股份、可转换公司债券及支付现金的方式购买张关明、苏州 讯诺投资合伙企业（有限合伙）（以下简称"讯诺投资"）、刘晓明、杜文刚、 沙淑丽、于壮成合计 6 名交易对方合计持有的苏州安捷讯光电科技股份有限公司 （以下简称"标的公司"）的 100%股权（以下简称"本次交 ...

Overview of the Transaction - The company plans to acquire 51% equity of Hunan Huize Biomedical Technology Co., Ltd. in cash, which will make Huize a subsidiary and included in the consolidated financial statements [1][2] - The acquisition aims to enhance the company's industrial chain layout by leveraging Huize's technology and customer resources in drug research and clinical evaluation, which are highly synergistic with the company's existing biopharmaceutical business [2][10] - The agreement signed is a preliminary intention agreement and does not involve specific contract amounts; it is subject to further negotiation and due diligence [2][9] Parties Involved - The transferors include individuals and partnerships that do not have any related party relationships with the company and are not listed as dishonest executors [3][4][5] Target Company Information - Hunan Huize Biomedical Technology Co., Ltd. is a specialized CRO company focused on drug research and clinical evaluation, with over 85% of its revenue coming from clinical evaluation services [5][6] - The company has established long-term partnerships with over 300 domestic and international pharmaceutical companies and research institutions, completing more than 1,000 technical service projects [6][10] Financial and Operational Aspects - The registered capital of Huize is approximately 11.1 million yuan, and it has been recognized as a national high-tech enterprise and a key "little giant" enterprise [5][6] - The main business includes drug wholesale and retail, clinical trial services, and various technical services related to medical research and development [5][6] Purpose and Impact of the Acquisition - The acquisition is expected to enhance the company's biopharmaceutical segment, improve profitability, and strengthen risk resistance [10] - It will also integrate clinical transformation research and drug development, leading to improved operational efficiency and significant synergies [10] - Overall, the transaction is aligned with the company's strategic development needs and aims to foster long-term sustainable growth [10]

Group 1 - The company held an emergency board meeting on August 11, 2025, to ensure efficient operations and timely information disclosure, with all seven directors present [1][2] - The board approved the termination of the asset acquisition plan involving the purchase of 96.9628% equity in Beijing Tianyi Enhua Technology Co., Ltd., due to a lack of consensus on core transaction terms after thorough negotiations [1][2] - The management has been authorized to handle all matters related to the termination of this transaction, effective from the date of the board's approval until the completion of the termination process [1]

Core Viewpoint - The company is facing a significant risk due to the upcoming auction of its major asset, the Shenzhen Huangting Plaza, which could lead to a substantial impact on its financial stability and operations [1] Group 1: Auction Details - The Shenzhen Intermediate Court will auction the company's wholly-owned subsidiary, Rongfa Investment's asset, the Shenzhen Huangting Plaza, on September 9-10, with a starting price of 3.053 billion yuan [1] - The auction includes the shopping center and related facilities and equipment [1] Group 2: Financial Impact - As of the end of 2024, the book value of Shenzhen Huangting Plaza is 5.75 billion yuan, accounting for 71.57% of the company's total assets [1] - The projected revenue from the Shenzhen Huangting Plaza for 2024 is 369 million yuan, representing 56.03% of the company's total revenue for the year [1] Group 3: Consequences of Auction - If the auction is successful, the company will lose ownership of a major asset, constituting a significant asset restructuring [1] - The loss of this key asset may lead to substantial effects on the company's assets, liabilities, and daily operations, potentially triggering financial warning signs for forced delisting [1]

Core Viewpoint - The company is facing a significant risk of losing its major asset, the Shenzhen Huangting Plaza, due to a court-ordered auction scheduled for September 9-10, 2025, with a starting price of 3.053 billion yuan [1] Group 1: Asset Auction Details - The Shenzhen Intermediate People's Court will auction the company's wholly-owned subsidiary, Rongfa Investment's asset, the Crystal Island Commercial Center (Shenzhen Huangting Plaza) [1] - The auction is set to take place on the JD.com judicial auction platform, with a starting price of 3.053 billion yuan [1] Group 2: Impact on Company - If the auction is successful, the company will lose ownership of the asset, constituting a major asset restructuring [1] - The auction outcome could significantly affect the company's assets, liabilities, and daily operations, potentially triggering financial warning signs under the Shenzhen Stock Exchange's listing rules [1] Group 3: Debt Resolution Efforts - The company is currently negotiating with creditors to reach a comprehensive settlement plan, including debt resolution [1] - Both parties are actively working towards an early resolution, which could lead to the court canceling the auction if an agreement is reached [1] - Successful implementation of the settlement plan may positively impact the company's future financial status and operations [1]

Core Viewpoint - The major asset restructuring of Haikong Group has faced significant delays and uncertainties, with no clear resolution in sight after more than three years of attempts [1][5][8]. Restructuring Progress - Haikong Group announced on August 8 that the completion of the restructuring remains uncertain, dependent on negotiations with the transaction party and other approvals [1][5]. - The restructuring plan has undergone three modifications, with the latest adjustment involving a shift from equity issuance to cash and/or asset payments, abandoning the fundraising component [7][8]. Financial Performance - Haikong Group has experienced continuous financial pressure, with a cumulative net loss of 569 million since 2020, and a projected loss of 26 to 32 million for the first half of 2025 [3][10][11]. - The company's asset-liability ratio reached 70.70% by the end of the first quarter of 2025, indicating significant financial strain [4][11]. Market Conditions - The performance of Haikong Group's target acquisition, Hainan Duty-Free, has not met expectations due to rapid changes in the duty-free market and increased competition [2][8]. - The traditional passenger transport sector, which is a core part of Haikong Group's business, has been shrinking, contributing to ongoing losses [3][11]. Historical Context - The restructuring process began in May 2022, with an initial valuation of Hainan Duty-Free at 5 billion yuan, which has since been revised down multiple times due to underperformance [6][10]. - The company's revenue has declined from approximately 1.3 billion yuan in 2012 to around 840 million yuan in 2024, reflecting a downward trend in its core operations [10].

Core Viewpoint - Binhai Energy (000695) is currently undergoing a major asset restructuring process, which is in the stages of due diligence, auditing, and evaluation, with further steps required for completion [1] Trading Information Summary - On August 8, 2025, Binhai Energy's stock closed at 11.86 yuan, down 0.42%, with a turnover rate of 1.85% and a trading volume of 41,100 shares, resulting in a transaction amount of 48.6953 million yuan [1] - On the same day, the net outflow of funds from major investors was 3.9355 million yuan, accounting for 8.08% of the total transaction amount; net outflow from speculative investors was 2.5624 million yuan, making up 5.26%; while retail investors saw a net inflow of 6.4979 million yuan, representing 13.34% of the total transaction amount [1]